Journal article
New strategies for prevention of ischemic stroke: the LIFE study
Current neurology and neuroscience reports, Vol.3(1), pp.46-51
01/2003
DOI: 10.1007/s11910-003-0036-7
PMID: 12507410
Abstract
New strategies to lower the risk of stroke among high-risk persons are being developed. Therapies such as cholesterol-lowering medications and newer antihypertensive agents appear to complement traditional antithrombotic drugs and surgical procedures. Of particular interest is the use of the newer angiotensin-converting enzyme (ACE) inhibitors, which appear to have an effect on stabilizing the vascular endothelium. The Losartan Intervention For Endpoint (LIFE) reduction in hypertension study provides additional data to support the use of the ACE inhibitors to lower the risk of stroke among patients with hypertension and vascular diseases.
Details
- Title: Subtitle
- New strategies for prevention of ischemic stroke: the LIFE study
- Creators
- Harold P Adams - Department of Neurology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52246, USA. harold-adams@uiowa.edu
- Resource Type
- Journal article
- Publication Details
- Current neurology and neuroscience reports, Vol.3(1), pp.46-51
- Publisher
- United States
- DOI
- 10.1007/s11910-003-0036-7
- PMID
- 12507410
- ISSN
- 1528-4042
- eISSN
- 1534-6293
- Language
- English
- Date published
- 01/2003
- Academic Unit
- Neurology; Iowa Neuroscience Institute
- Record Identifier
- 9984020625102771
Metrics
9 Record Views